IQVIA Holdings Inc. (I1QV34)
Sao Paulo Exchange · Brazil · prices in BRL · close of 15 Oct 2026
Key indicators
| Last close | BRL 79.70 |
|---|---|
| 52-week range | 49.30 – 328.55 |
| Return, 1 month / 3 months | −5.6% / +21.3% |
| Return, 1 year / 3 years | +16.8% / +26.6% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 46 |
| Volatility (1 year) | 281.1% |
| Worst drawdown (1 year) | -75.7% |
| Average daily value traded | 0.01M BRL |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
IQVIA Holdings is a healthcare information and clinical research company. It provides data, analytics and consulting services to pharmaceutical, biotechnology and medical device companies, and it runs clinical trials and other outsourced research work for those customers. Its services help clients understand markets, develop medicines and manage clinical studies. The company is based in the United States and serves healthcare and life sciences customers around the world.
IQVIA Holdings Inc. is represented on the Sao Paulo Exchange in Brazil by a Brazilian depositary receipt (BDR) under the code I1QV34, with its price quoted in Brazilian reais (BRL). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
IQVIA Holdings Inc. (I1QV34) trades on the Sao Paulo Exchange in Brazil. It last closed at BRL 79.70 on 15 October 2026.
Its price-based Market X-Ray is 46 out of 100 (a weak price profile), ranking 909 of 1,454 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 16.8% and over the last three months it rose 21.3%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Sao Paulo Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 60 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 15.4% | ||
| From 52-week high | -75.7% | ||
| Momentum | 83 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 21.3% | ||
| 6-month return | 43.3% | ||
| 12-month return, skipping the last month | 23.7% | ||
| Stability (higher is calmer) | 5 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 281.1% | ||
| Worst drawdown, 1 year (smaller is calmer) | -75.7% | ||
| Liquidity | 27 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.01M BRL | ||
| Zero-volume days | 80.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 0 |
Strengths
- Momentum: Rising faster than most stocks on this exchange.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | −2.3% |
|---|---|
| 1 month | −5.6% |
| 3 months | +21.3% |
| 6 months | +43.3% |
| 1 year | +16.8% |
| 3 years | +26.6% |
| 5 years | – |
Signals
| 50-day / 200-day average | 91.87 / 69.05 |
|---|---|
| Golden / death cross (60 days) | Golden, 41 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 4.06 |
Technical summary
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Sao Paulo Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.